8000 MARINA BLVD, BRISBANE, CA
Bylaws Amendment - GT Biopharma Reduces Quorum Requirements
News
GT Biopharma Enters Investigator Initiated Clinical Trial Agreement
Reports Third Quarter 2025 Financial Results and Provides Corporate Update
News, Material Contracts
Q2
Q1
Amended Quarterly Report
FY 2025
Q3
Prospectus filed pursuant to Rule 424(b)(3)
Effectiveness Notice
S-1
Definitive Proxy Statement
PRE 14A
Additional Proxy Materials
Statement of Changes in Beneficial Ownership
Initial Statement of Beneficial Ownership
Correspondence
Submission Upload